SF
RMD icon

Synovus Financial’s ResMed RMD Stock Holding History

Synovus Financial’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20
Closed -$4K – 1285
2020
Q2 		$4K Sell
20
-425
-96% -$69.5K ﹤0.01% 1359
2020
Q1 		$65K Buy
445
+370
+493% +$58.9K ﹤0.01% 1032
2019
Q4 		$12K Hold
75
– – ﹤0.01% 1188
2019
Q3 		$10K Hold
75
– – ﹤0.01% 1193
2019
Q2 		$9K Hold
75
– – ﹤0.01% 1142
2019
Q1 		$8K Hold
75
– – ﹤0.01% 1155
2018
Q4 		$9K Hold
75
– – ﹤0.01% 1100
2018
Q3 		$9K Hold
75
– – ﹤0.01% 1147
2018
Q2 		$8K Buy
+75
New +$7.59K ﹤0.01% 1087

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Synovus Financial's RMD Position: Q3 2020 in Review

Synovus Financial sold out of ResMed (RMD) in Q3 2020, closing a stake of 20 shares — an estimated $4K sold.

Synovus Financial first reported a position in RMD in Q2 2018 and held it in 9 quarters. The position peaked at $65K in Q1 2020. 626 funds tracked by Wall St. Rank hold RMD as of Q3 2020.

  • Synovus Financial reported no remaining ResMed position as of Q3 2020 after selling out during the quarter.
  • Synovus Financial sold 20 ResMed shares in Q3 2020, an estimated $4K.
  • Synovus Financial first reported a position in ResMed in Q2 2018 and held it in 9 quarters.
  • Synovus Financial's ResMed position peaked at $65K in Q1 2020.
  • 626 funds tracked by Wall St. Rank held ResMed as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.